The Importance of Genetic Testing for Prostate Cancer P2

September 28, 2020
All Posts

In the second webinar installment partnered with Prostate Health Education Network (PHEN), Dr. Keith Crawford MD, PHD will discuss new treatment and clinical trials for men with metastatic castration-resistant prostate cancer, and how these treatments use genetic information to attack cancers.

Dr. Crawford gives insight as to how these new treatments referred to as DNA repair inhibitors kill cancer cells with damaged DNA without hormone therapy or chemotherapy.

Click here to watch the webinar: Part 2

Click here watch Part 1 of the webinar: Part 1

Metastatic Cancer? Request a Mets Patient Guide